Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Oncosurgeon, Head of Samsung Department of Urology

プロフェッサー ドクター エドゥアルド・ベヒトはドイツで41年の経験を持つ泌尿器科医であり、アテネのカポディアストリアス大学から名誉博士号を授与されています。彼の主なポイントは以下の通りです:

• "フランクフルト・アム・マイン eV インターディシプリナリー ユロオンコロジー" 協会の会長
• 1972年にマインツのヨハネス グーテンベルク大学を卒業
• 1980年に同大学の医療クリニック、腎臓病学科で博士号を取得
• 1994年からフランクフルト・アム・マインのゲーテ大学で講師を務める
• 泌尿器科腫瘍学、前立腺癌の低侵襲治療、臓器保存腎腫瘍手術、前立腺腺腫の治療、再建泌尿器科、尿道手術、小児泌尿器科、腎臓結石治療などの分野に注力
• 彼のクレジットに100以上の科学論文がある

Urologist, Surgeon

この医師は、イスタンブールのMedical Park Gaziosmanpaşa Hospitalで著名な泌尿器科医であり、アンカラ大学医学部での広範な教育と、Selcuk University Faculty of Medicineでの専門教育を受けています。Selcuk Universityの准教授として、後にCleveland Clinic Ohioの教授として、医師は尿路腫瘍学に焦点を当てました。専門分野には、男性不妊症とインポテンス、神経泌尿器学、マイクロ血管手術が含まれ、University of PittsburghとMercy Universityでの研修を受けています。

医師は国際的なインデックスに16の科学論文を、国内の雑誌に58の論文を発表し、様々な会議で47のコミュニケを行い、49の国際的な引用があります。医師は国内の泌尿器科およびアンドロロジー会議で、講演者およびセッションチェアマンとして積極的に参加しています。

Head of the Urology Department, Oncosurgeon

Dr. Vladimir Yutkin Vladimir Yutkin is a highly experienced doctor at the Hadassah Medical Center, with over 20 years of experience. Key takeaways:

• Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem (Israel) in 1996;
• Over 20 years of experience;
• Specialty is diagnosis and treatment of temporomandibular joint disorders;
• Speaks English, Hebrew, and Russian.

オファー・ナタン・ゴフリット教授は、泌尿器科医です。ハダッサ医療センター泌尿器科の主任医師です。米国シカゴ大学病院で侵襲的泌尿器科と腫瘍学のインターンシップを完了しました。ロボット手術を行う資格を取得しました。

ヘブライ大学で泌尿器科手術を教えています。膀胱と腎臓の腫瘍性疾患の研究を行っています。多数の科学論文や記事の著者です。泌尿器科への貢献で国内外のプロフェッショナルな賞を受けています。

専門分野：

• 男性および女性の泌尿生殖器系疾患の外科的治療;
• 膀胱と前立腺の癌治療;
• 泌尿器内視鏡手術;
• ダ・ヴィンチロボットを使用した手術 .

Tamar Jablonski-Perec is an oncologist at the Hadassah Medical Center who received her Doctor of Medical Sciences at the Hebrew University in Jerusalem and completed an internship at the renowned Sloan-Kettering Cancer Center in New York. Her key takeaways include:

• Head of Institute of Oncology in 1994
• Head of Breast Cancer Treatment Center in 1998
• Professor of the Department of Oncology at the Hebrew University in 2006
• Member of several international cancer communities
• Awarded a scholarship from the Hadassah Medical School

Radiotherapist

Urologist, Specialist in Oncourology

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.